Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superfractionation: its rationale and anticipated benefits

B G Douglas

    International Journal of Radiation Oncology, Biology, Physics
    |July 1, 1982
    PubMed
    Summary

    Superfractionation in radiation therapy, using smaller doses more frequently, can improve tumor control. However, this benefit is reduced if tumors have a high capacity for radiation injury repair.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation. 1976.

    Radiation research·2012
    Same author

    Preclinical evaluation of pions in vivo: experience at TRIUMF.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·1990
    Same author

    Superfractionated radiotherapy in grade III, IV intracranial gliomas.

    International journal of radiation oncology, biology, physics·1988
    Same author

    The response of mouse epidermis to fractionated doses of pi mesons.

    International journal of radiation oncology, biology, physics·1987
    Same author

    Pions and pig skin: preclinical evaluation of RBE for early and late damage.

    International journal of radiation oncology, biology, physics·1986
    Same author

    In vitro and in vivo studies of the TRIUMF pion therapy beam.

    Radiation research. Supplement·1985

    Area of Science:

    • Radiation Oncology
    • Radiobiology
    • Medical Physics

    Background:

    • Understanding the biological effects of radiation dose fractionation is crucial for optimizing radiation therapy.
    • The quadratic cell survival equation (S = e-(alpha D + beta D2)) provides a theoretical framework for analyzing radiation response.
    • Key metrics like therapeutic ratio and therapeutic gain are essential for evaluating treatment efficacy.

    Purpose of the Study:

    • To explore the biological underpinnings of radiation therapy dose fractionation.
    • To theoretically evaluate the implications of the quadratic cell survival equation on treatment outcomes.
    • To assess the utility of therapeutic ratio and therapeutic gain in optimizing fractionation schedules.

    Main Methods:

    • Theoretical analysis based on the quadratic cell survival equation.
    • Development and application of therapeutic ratio and therapeutic gain metrics.
    • Modeling of normal tissue and tumor cell responses to varying fractionation schemes.

    Main Results:

    • Superfractionation (small doses at short intervals) can enhance local tumor control.
    • This improvement is contingent on increasing total dose to maintain normal tissue tolerance.
    • Tumor response may be limited by oxygenated cells with superior sublethal damage repair capacity compared to normal tissues.

    Conclusions:

    • Optimizing radiation dose fractionation, particularly through superfractionation, holds promise for improved cancer treatment.
    • Careful consideration of cellular radiation repair capacity is necessary to maximize therapeutic benefits.
    • The quadratic cell survival model and derived metrics offer valuable insights into radiation therapy dose optimization.

    Related Experiment Videos